[Event Report] The Third Advisory Board Meeting for the Immunization and Vaccination Policy Promotion Project, “Data Collection and Application to Appropriately Evaluate Vaccination Outcomes” (November 10, 2020)
date : 12/1/2020
Tags: Vaccinations
Health and Global Policy Institute (HGPI) held the third advisory board meeting for the Immunization and Vaccination Policy Promotion Project, entitled “Data Collection and Application to Appropriately Evaluate Vaccination Outcomes .”
Following the discussion at the first meeting, the discussion held at the third advisory board meeting focused on issues encountered during the three stages of data collection, data comparison and sharing when using multiple databases, and evaluating collected data when using databases containing information related to vaccine coverage, the survey system on infectious diseases, and reports of adverse vaccine reactions.
Various points that will need to be considered to achieve a life-course approach were raised during the discussion. These included the significance of clearly demonstrating vaccine effects by developing databases; the future possibilities of information disclosure, related personal information protection, and their legal provisions; and the current situation surrounding the digitization of vaccine records by the Japanese Government as well as its relation to the vaccine surveillance system.
Due to the circumstances regarding the COVID-19 pandemic, this meeting was held online.
■Overview
Date & Time: Tuesday, September 15, 2020
Organizer: Health and Global Policy Institute
■Advisory Board Members and Observers (alphabetical order by last name)
Members:
- Kyoko Ama (Former Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
- Hidenori Arai (President, National Center for Geriatrics and Gerontology; Vice President, The Japan Geriatrics Society)
- Satoshi Iwata (Department of Infectious Diseases, National Cancer Center Hospital)
- Isao Miyairi (Medical Director, Department of Infectious Diseases, National Center for Child Health and Development)
- Kuniko Nakayama (Director, My Family Clinic Gamagori, Medical Association Mefa Jinaikai)
- Akihiko Saitoh (Professor, Department of Pediatrics, Graduate School of Medical and Dental Sciences, Niigata University)
- Akinori Sugaya (Head Physician, Sugaya Children’s Clinic; Director, KNOW VPD Protect Our Children)
- Mugen Ujiie (Director of Travel Clinic, Director of Immunization Support Center, Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine (NCGM))
Observers:
- Masayuki Imagawa (Representative Director, Japan Vaccine Industry Association (President))
- Naoki Karayama (Senior Expert, Public Relations Division, GlaxoSmithKline K.K.)
- Shiori Masuda (Chief, Vaccine Market Access Division, GlaxoSmithKline K.K.)
- Yukiko Nakatani (Director, Blood and Blood Products Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW)
- Leon Ochiai (Head, Public Relations Division, Responsible for Vaccine, Sanofi K.K.)
- Naokazu Saito (Director, Policy Intelligence Department, Janssen Pharmaceutical K.K.)
- Daisaku Sato (Chief Management Officer & Associate Centre Director for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Japan)
Moderator:
- Ryoji Noritake (CEO, Board Member, HGPI)
MC:
- Joji Sugawara (Senior Associate, HGPI)
Secretariat:
- Yui Kohno (Associate, HGPI)
- Yuka Nakamura (Intern, HGPI)
- Ryuta Saito (Assistant, HGPI)
■Related contents held as part of the project (chronological order)
– September 7, 2020 [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines
日本語
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-02
[Event Report] The 123rd HGPI Seminar – The Current Situation and Future Prospects for Epilepsy in Japan and Around the World (March 6, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session